IJSRP, Volume 4, Issue 3, March 2014 Edition [ISSN 2250-3153]
Marcus S. MD, DNB., Mahajan MK. MD, MNAMS, Grover S. MD, DNB, DGO, 4Sachdev J. MD, Jeyaraj P. MD, Mukhopadhyay S. MD
Abstract:
Tamoxifen acts as an estrogen agonist on the female genital tract. The side effect of major concern is endometrial carcinoma.
Marcus S. MD, DNB., Mahajan MK. MD, MNAMS, Grover S. MD, DNB, DGO, 4Sachdev J. MD, Jeyaraj P. MD, Mukhopadhyay S. MD (2018); Significance and prevalence of Tamoxifen related endometrial changes in patients of carcinoma breast;
Int J Sci Res Publ 4(3) (ISSN: 2250-3153). http://www.ijsrp.org/research-paper-0314.php?rp=P272430
Significance and prevalence of Tamoxifen related endometrial changes in patients of carcinoma breast
